spirogermanium has been researched along with Benign Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlgren, JD; Byrne, PJ; Priego, VM; Schein, PS; Woolley, PV | 1 |
| Blanc, O; Davis, J; Slavik, M | 1 |
| Gesme, DH; Kennedy, BJ; Vogelzang, NJ | 1 |
1 trial(s) available for spirogermanium and Benign Neoplasms
| Article | Year |
|---|---|
A phase II study of spirogermanium in advanced human malignancy.
Topics: Adult; Aged; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Female; Germanium; Half-Life; Humans; Infusions, Parenteral; Kinetics; Male; Middle Aged; Neoplasms; Organometallic Compounds; Spiro Compounds | 1985 |
2 other study(ies) available for spirogermanium and Benign Neoplasms
| Article | Year |
|---|---|
A Phase I trial of spirogermanium administered on a continuous infusion schedule.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Germanium; Humans; Infusions, Parenteral; Male; Middle Aged; Neoplasms; Nervous System; Organometallic Compounds; Phlebitis; Spiro Compounds | 1984 |
Spirogermanium: a new investigational drug of novel structure and lack of bone marrow toxicity.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Chemical Phenomena; Chemistry; Dogs; Drug Evaluation; Germanium; Humans; Mice; Neoplasms; Neoplasms, Experimental; Organometallic Compounds; Spiro Compounds | 1983 |